0001567619-22-014272.txt : 20220720
0001567619-22-014272.hdr.sgml : 20220720
20220720191849
ACCESSION NUMBER: 0001567619-22-014272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220718
FILED AS OF DATE: 20220720
DATE AS OF CHANGE: 20220720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TREACE JAMES T
CENTRAL INDEX KEY: 0001185191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 221095349
MAIL ADDRESS:
STREET 1: 117 BRISTOL PLACE
CITY: PONTE VEDRA BEACH
STATE: FL
ZIP: 32082
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 471052611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
doc1.xml
FORM 4
X0306
4
2022-07-18
0
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001185191
TREACE JAMES T
C/O TREACE MEDICAL CONCEPTS, INC.
203 FORT WADE ROAD, SUITE 150
PONTE VEDRA
FL
32081
1
0
0
0
Common Stock
2022-07-18
4
S
0
12978
16.058
D
1257663
D
Common Stock
2022-07-18
4
S
0
983
16.4568
D
1256680
D
Common Stock
2022-07-19
4
S
0
20239
16.1121
D
1236441
D
Common Stock
556183
D
Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.37 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.39 to $16.51 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.62 to $16.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Lisa Taylor, as Attorney-in-fact for James T. Treace
2022-07-20